Skip to main content
NVDA+0.04%AAPL+0.06%MSFT+0.25%GOOGL+1.19%AMZN+0.25%TSM+2.95%SPCX+1.14%AVGO+4.00%TSLA+0.10%META-0.08%LLY+0.22%BRK-B-1.02%MU+0.83%SKHY+1.92%WMT-0.81%AMD+5.45%JPM+0.52%V-0.57%XOM-2.53%JNJ+0.91%ASMLa+2.80%MA-0.59%ABBV-0.10%INTC+3.61%1398.HK+2.15%CVX-1.59%0700.HK-0.31%COST-1.30%CSCO+1.03%ORCL+3.55%KO-1.64%PG-0.45%UNH-0.08%BAC+0.32%1816.HK+1.32%3988.HK+0.66%CAT+3.06%DELL+7.38%HD-0.28%0857.HK-0.98%PM+0.37%AP2d+2.18%AMAT+2.15%0939.HK+0.81%GE+3.20%1288.HK+0.60%LRCX+1.41%NVS+1.98%0005.HK-5.56%MS+1.91%USDJPY+0.73%AUDJPY+0.67%EURUSD-0.67%EURAUD-0.60%GBPUSD-0.50%USDCHF+0.47%GBPAUD-0.44%AUDCHF+0.42%CADJPY+0.42%GBPTRY+0.41%NZDJPY+0.40%EURNZD-0.36%EURCAD-0.33%NZDUSD-0.32%USDCAD+0.32%GBPHKD+0.32%GBPMXN-0.28%USDTRY+0.27%CHFJPY+0.27%AUDNZD+0.26%AUDCAD+0.25%GBPJPY+0.22%EURCHF-0.21%GBPCAD-0.20%GBPNZD-0.17%USDILS+0.16%EURGBP-0.16%NZDCHF+0.15%CADCHF+0.15%AUDSGD+0.08%EURJPY+0.07%AUDUSD-0.06%CHFSGD+0.05%AUDNOK+0.05%NZDMXN+0.05%EURCNH+0.04%EURSGD+0.04%USDDKK-0.04%USDCOP-0.04%GBPCHF-0.04%USDTHB+0.04%USDMXN+0.03%USDHKD+0.03%USDCNH-0.03%USDZAR+0.03%SGDJPY+0.02%NZDSGD+0.02%GBPSGD+0.02%NZDCAD-0.01%USDSGD0.00%EURPLN0.00%CHFNOK0.00%PLNJPY0.00%USDSEK0.00%USDPLN0.00%NOKJPY0.00%EURHKD0.00%EURCZK0.00%EURNOK0.00%GBPZAR0.00%EURZAR0.00%EURDKK0.00%AUDDKK0.00%CHFSEK0.00%USDNOK0.00%EURSEK0.00%XNGUSD+0.44%XPTUSD+0.26%USOIL-0.21%XAGUSD+0.10%GAGUSD+0.09%GAUUSD+0.01%XAUUSD+0.01%HG1+0.01%C10.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.19%ETHUSD+23.96%USDTUSD+0.05%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT+0.82%ZECUSDT+6.84%DOGEUSD+20.65%XMRUSDT+1.41%LINKUSD+25.58%BCHUSDT+5.43%XLMUSD+0.78%UNIUSD-0.77%LTCUSD+17.89%SUIUSD+1.84%HBARUSDT-1.47%TONUSD+41.71%TAOUSDT+2.01%AAVEUSD-1.29%DOTUSDT-0.79%ICPUSDT-1.07%ONDOUSDT+1.30%WLDUSDT+1.06%ARBUSDT-0.86%JUPUSDT+0.66%INJUSDT-0.95%ATOMUSDT-0.51%STXUSDT-1.08%TIAUSDT-1.79%FETUSDT+4.41%PYTHUSDT-2.47%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+1.22%OPUSDT-0.20%WIFUSDT-0.61%IOTAUSDT+1.36%POLUSDT+1.53%AXSUSDT+1.25%EOSUSDT+1.48%FARTCOINUSDT+2.48%DYDXUSDT+3.03%GALAUSDT+2.14%ORDIUSDT+3.11%RONINUSDT+1.89%NOTUSDT+4.64%NVDA+0.04%AAPL+0.06%MSFT+0.25%GOOGL+1.19%AMZN+0.25%TSM+2.95%SPCX+1.14%AVGO+4.00%TSLA+0.10%META-0.08%LLY+0.22%BRK-B-1.02%MU+0.83%SKHY+1.92%WMT-0.81%AMD+5.45%JPM+0.52%V-0.57%XOM-2.53%JNJ+0.91%ASMLa+2.80%MA-0.59%ABBV-0.10%INTC+3.61%1398.HK+2.15%CVX-1.59%0700.HK-0.31%COST-1.30%CSCO+1.03%ORCL+3.55%KO-1.64%PG-0.45%UNH-0.08%BAC+0.32%1816.HK+1.32%3988.HK+0.66%CAT+3.06%DELL+7.38%HD-0.28%0857.HK-0.98%PM+0.37%AP2d+2.18%AMAT+2.15%0939.HK+0.81%GE+3.20%1288.HK+0.60%LRCX+1.41%NVS+1.98%0005.HK-5.56%MS+1.91%USDJPY+0.73%AUDJPY+0.67%EURUSD-0.67%EURAUD-0.60%GBPUSD-0.50%USDCHF+0.47%GBPAUD-0.44%AUDCHF+0.42%CADJPY+0.42%GBPTRY+0.41%NZDJPY+0.40%EURNZD-0.36%EURCAD-0.33%NZDUSD-0.32%USDCAD+0.32%GBPHKD+0.32%GBPMXN-0.28%USDTRY+0.27%CHFJPY+0.27%AUDNZD+0.26%AUDCAD+0.25%GBPJPY+0.22%EURCHF-0.21%GBPCAD-0.20%GBPNZD-0.17%USDILS+0.16%EURGBP-0.16%NZDCHF+0.15%CADCHF+0.15%AUDSGD+0.08%EURJPY+0.07%AUDUSD-0.06%CHFSGD+0.05%AUDNOK+0.05%NZDMXN+0.05%EURCNH+0.04%EURSGD+0.04%USDDKK-0.04%USDCOP-0.04%GBPCHF-0.04%USDTHB+0.04%USDMXN+0.03%USDHKD+0.03%USDCNH-0.03%USDZAR+0.03%SGDJPY+0.02%NZDSGD+0.02%GBPSGD+0.02%NZDCAD-0.01%USDSGD0.00%EURPLN0.00%CHFNOK0.00%PLNJPY0.00%USDSEK0.00%USDPLN0.00%NOKJPY0.00%EURHKD0.00%EURCZK0.00%EURNOK0.00%GBPZAR0.00%EURZAR0.00%EURDKK0.00%AUDDKK0.00%CHFSEK0.00%USDNOK0.00%EURSEK0.00%XNGUSD+0.44%XPTUSD+0.26%USOIL-0.21%XAGUSD+0.10%GAGUSD+0.09%GAUUSD+0.01%XAUUSD+0.01%HG1+0.01%C10.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.19%ETHUSD+23.96%USDTUSD+0.05%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT+0.82%ZECUSDT+6.84%DOGEUSD+20.65%XMRUSDT+1.41%LINKUSD+25.58%BCHUSDT+5.43%XLMUSD+0.78%UNIUSD-0.77%LTCUSD+17.89%SUIUSD+1.84%HBARUSDT-1.47%TONUSD+41.71%TAOUSDT+2.01%AAVEUSD-1.29%DOTUSDT-0.79%ICPUSDT-1.07%ONDOUSDT+1.30%WLDUSDT+1.06%ARBUSDT-0.86%JUPUSDT+0.66%INJUSDT-0.95%ATOMUSDT-0.51%STXUSDT-1.08%TIAUSDT-1.79%FETUSDT+4.41%PYTHUSDT-2.47%SEIUSDT+0.54%IMXUSDT+0.07%GRTUSDT+1.22%OPUSDT-0.20%WIFUSDT-0.61%IOTAUSDT+1.36%POLUSDT+1.53%AXSUSDT+1.25%EOSUSDT+1.48%FARTCOINUSDT+2.48%DYDXUSDT+3.03%GALAUSDT+2.14%ORDIUSDT+3.11%RONINUSDT+1.89%NOTUSDT+4.64%
O&

Organon & Co. (OGN)

NYSE • Healthcare

$13.75
+$0 (+0.1%)
Market closed

Last close at October 27, 2026 at 20:00 UTC

Open$13.75
Day Range$13.74 - $13.78
Avg. Volume (3M)2.1M
Market Cap$3.6B
P/E Ratio17.4
52 Week Range
$5.69$13.83
Next EarningsIn 13 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$1.5B100%
Gross Profitminus cost of goods$847M54%
Operating Incomeminus R&D and overhead$323M21%
Net Incomeminus taxes and the rest$108M7%

In plain terms: out of every $100 in revenue, Organon & Co. keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$6.1B
Net Income (TTM)
$209M
EPS (TTM)
$0.79
ROA (TTM)
1.59%
Current Ratio
1.95
Dividend Yield
0.17%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-13.7%Q1 2026$0.63
-14.5%Q2 2026$0.71
0.0%Q3 2026$0.85
Next

Nov 9

in 13 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Met

Organon & Co. missed consensus on adjusted EPS in the second fiscal quarter of 2026, posting $0.85 versus the $0.90 estimate, roughly -5.7%, and the results were reported on July 31, 2026. Adjusted EPS was down 15% from $1.00 a year ago, operating cash flow was negative about $224.7 million, and the company paid $5.0 million in dividends.

Next report — what to expect

Organon & Co. (OGN) reports on November 9, 2026. Wall Street is expecting EPS of $0.88 on revenue of $1.58 billion. For trailing context, revenue declined -2.3% year over year last quarter. Organon has beaten EPS in 3 of its 8 most recent quarters.

View full earnings history

About Organon & Co.

Organon & Co. develops and markets prescription medicines in healthcare, with a portfolio centered on women's health, biosimilars, and established therapies; it trades on the NYSE under OGN and recorded $6.2 billion in revenue in FY2025. The company operates as a drug manufacturer with products used across reproductive care, chronic disease, and allergy treatment.

Name
Organon & Co.
CEO
Joseph T. Morrissey Jr.
Website
www.organon.com
Industry
Healthcare
Year Founded
2020
Employees
10,000

Today's Snapshot

AI-generated

OGN ended the day slightly higher at 13.75, in line with a flat sector. OGN closed within 0.6% of its 52-week high of 13.83.

Trading Volume

Below 10d avg (2.2M)

1.8M

vs S&P 500 Today

Underperforming Market

-0.62%

Updated: October 27, 2026 at 20:22 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
OGN displays a constructive technical stance as the ADX indicates a relatively firm trend and the market trades above most medium and long moving averages, notably well above the 200‑day level. Momentum indicators are largely neutral to modestly positive and volatility is very low, compressing near narrow Bollinger ranges, while the pivot price aligns with the current level as a reference. On‑balance volume is mixed against the trend, so breadth is unclear. Technical takeaway: buy bias supported by trend strength and price above key averages, with low volatility and mixed volume confirmation.
All signals
  • EMA (5 indicators)$11.36 - $13.75
    Buy
  • RSI (14)52.71
    Neutral
  • Stochastic %K (14, 3, 3)24.24
    Neutral
  • MACD Level (12, 26)0.01
    Neutral

Peers & Related Assets

GRDNGuardian Pharmacy Services, Inc.
$39.56+0.9%
MDPediatrix Medical Group, Inc.
$28.84-0.7%
AUPHAurinia Pharmaceuticals Inc.
$17.25+1.2%
HRMYHarmony Biosciences Holdings, Inc.
$37.95+3.0%
NUVBNuvation Bio Inc.
$4.55+0.9%
PAHCPhibro Animal Health Corporation
$38.38-1.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.